Detalles de la búsqueda
1.
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.
Hepatology
; 58(2): 524-37, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23348636
2.
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.
Gastroenterology
; 142(4): 790-5, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22248659
3.
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
Lancet
; 376(9751): 1467-75, 2010 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20951424
4.
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model.
J Clin Oncol
; 39(6): 576-585, 2021 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33026937
5.
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry.
Clin Lymphoma Myeloma Leuk
; 20(3): 174-183.e3, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32033927
6.
Computerized extraction of electrocardiograms from continuous 12-lead holter recordings reduces measurement variability in a thorough QT study.
J Clin Pharmacol
; 52(12): 1891-900, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22187440
Resultados
1 -
6
de 6
1
Próxima >
>>